- Advertisement -

New catalysts remove NOx pollutants at lower temperatures

Bulk ‘defective’ vanadium oxide for NOx removal from industrial exhaust at temperatures lower than 150 degrees Celsius Credit: Tokyo Metropolitan University

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, announces the second phase of its on-going partnership with Neuro-Bio,...

Bath scientists identify promising route to develop new treatments for skin cancer

A promising route to develop new treatments for skin cancer has been identified by University of Bath scientists, who have found a molecule that...

From Good to Great: Bonum Therapeutics Raises $93M Series A with...

John Mulligan, PhD, founder and CEO at Bonum Therapeutics. Bonum Therapeutics, a biopharmaceutical startup that uses allosteric control to develop conditionally active and less toxic...

Bees’ ‘waggle dance’ may revolutionize how robots talk to each other...

Where are those flowers and how far away are they? This is the crux of the ‘waggle dance’ performed by honeybees to alert others...

Bombardier vs. assassin: Mimetic interactions via a shared enemy

Animals can defend themselves against their natural enemies in various ways. Well-defended species often share conspicuous body colors with other well-defended or undefended species,...

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

10x Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and single-cell...

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of...

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

10x Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and single-cell...

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of Tauopathy

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....

more new items

10x Clinical Expansion Advances with CLIA Lab Plans, Cleveland Clinic Partnership

10x Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and single-cell...

Protein Protects Against Tau Tangles, Synaptic Loss in Mouse Model of...

Alzheimer’s disease (AD) and many other forms of neurodegeneration share a common culprit. In these diseases, tau proteins that normally stabilize neuronal microtubule filaments...

Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics

Promise hits Parkinson’s disease therapy, as a Phase I/II clinical study has demonstrated the feasibility of transplanting stem-cell-derived dopamine progenitor cells into the brain....